Avalon Trust’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Avalon Trust’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,500	Closed	-$4.93K	–	463
2025 Q4	$4.93K	Hold	14,500	–	–	﹤0.01%	398
2025 Q3	$5K	Hold	14,500	–	–	﹤0.01%	437
2025 Q2	$3.19K	Hold	14,500	–	–	﹤0.01%	376
2025 Q1	$3.45K	Hold	14,500	–	–	﹤0.01%	402
2024 Q4	$3.04K	Hold	14,500	–	–	﹤0.01%	399
2024 Q3	$2.75K	Hold	14,500	–	–	﹤0.01%	308
2024 Q2	$2.94K	Hold	14,500	–	–	﹤0.01%	304
2024 Q1	$3.63K	Hold	14,500	–	–	﹤0.01%	308
2023 Q4	$2.79K	Hold	14,500	–	–	﹤0.01%	327
2023 Q3	$3.66K	Hold	14,500	–	–	﹤0.01%	290
2023 Q2	$5.73K	Hold	14,500	–	–	﹤0.01%	287
2023 Q1	$4.06K	Buy	+14,500	New	+$5.5K	﹤0.01%	288

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Avalon Trust's DRTSW Position: Q1 2026 in Review

Avalon Trust sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2026, closing a stake of 14,500 shares — an estimated $4.93K sold.

Avalon Trust first reported a position in DRTSW in Q1 2023 and held it in 12 quarters. The position peaked at $5.73K in Q2 2023. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

Avalon Trust reported no remaining Alpha Tau Medical Warrant position as of Q1 2026 after selling out during the quarter.
Avalon Trust sold 14,500 Alpha Tau Medical Warrant shares in Q1 2026, an estimated $4.93K.
Avalon Trust first reported a position in Alpha Tau Medical Warrant in Q1 2023 and held it in 12 quarters.
Avalon Trust's Alpha Tau Medical Warrant position peaked at $5.73K in Q2 2023.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.